U.S. markets close in 6 hours 18 minutes
  • S&P 500

    4,190.77
    -31.09 (-0.74%)
     
  • Dow 30

    33,464.34
    -359.11 (-1.06%)
     
  • Nasdaq

    14,116.62
    -44.73 (-0.32%)
     
  • Russell 2000

    2,287.46
    -27.23 (-1.18%)
     
  • Crude Oil

    70.92
    -0.12 (-0.17%)
     
  • Gold

    1,775.90
    +1.10 (+0.06%)
     
  • Silver

    26.05
    +0.19 (+0.73%)
     
  • EUR/USD

    1.1869
    -0.0041 (-0.34%)
     
  • 10-Yr Bond

    1.4950
    -0.0160 (-1.06%)
     
  • GBP/USD

    1.3842
    -0.0082 (-0.59%)
     
  • USD/JPY

    110.3950
    +0.1640 (+0.15%)
     
  • BTC-USD

    37,124.19
    -1,752.86 (-4.51%)
     
  • CMC Crypto 200

    918.11
    -21.84 (-2.32%)
     
  • FTSE 100

    7,035.50
    -117.93 (-1.65%)
     
  • Nikkei 225

    28,964.08
    -54.25 (-0.19%)
     

Are Chamath Palihapitiya's SPACs IPOD and IPOF Worth Buying Now?

·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Out of the six SPACs Chamath Palihapitiya has launched so far, there are two that have yet to identify their acquisition targets. In this Fool Live video clip, recorded on March 15, Fool.com contributors Matt Frankel, CFP, Brian Withers, and Dan Caplinger discuss whether these two blank-check companies might be worth a look now.